World Wide relies on analytics signals to operate securely and keep research services available. Accept to continue, or leave the site.
Review the Privacy Policy for details about analytics processing.
Prof
Showing your local timezone
Schedule
Wednesday, May 26, 2021
12:30 PM Australia/Melbourne
Seminar location
No geocoded details are available for this content yet.
Format
Past Seminar
Recording
Not available
Host
Ad hoc
Seminar location
No geocoded details are available for this content yet.
Cognitive control involves the flexible allocation of mental resources during goal-directed behaviour and comprises three correlated but distinct domains—inhibition, task shifting, and working memory. Healthy ageing is characterised by reduced cognitive control. Professor Cheryl Grady and her team have been studying the influence of age differences in large-scale brain networks on the three control processes in a sample of adults from 20 to 86 years of age. In this webinar, Professor Cheryl Grady will describe three aspects of this work: 1) age-related dedifferentiation and reconfiguration of brain networks across the sub-domains 2) individual differences in the relation of task-related activity to age, structural integrity and task performance for each sub-domain 3) modulation of brain signal variability as a function of cognitive load and age during working memory. This research highlights the reduction in dynamic range of network activity that occurs with ageing and how this contributes to age differences in cognitive control. Cheryl Grady is a senior scientist at the Rotman Research Institute at Baycrest, and Professor in the departments of Psychiatry and Psychology at the University of Toronto. She held the Canada Research Chair in Neurocognitive Aging from 2005-2018 and was elected as a Fellow of the Royal Society of Canada in 2019. Her research uses MRI to determine the role of brain network connectivity in cognitive ageing.
Cheryl Grady
Prof
neuro
neuro
The development of the iPS cell technology has revolutionized our ability to study development and diseases in defined in vitro cell culture systems. The talk will focus on Rett Syndrome and discuss t
neuro
Pluripotent cells, including embryonic stem (ES) and induced pluripotent stem (iPS) cells, are used to investigate the genetic and epigenetic underpinnings of human diseases such as Parkinson’s, Alzhe